C. difficile Infection Diagnosis and Management

Diagnostic Criteria

The Infectious Diseases Society of America recommends testing for C. difficile in patients with three or more unformed stools in 24 hours 4, 5
Recent antibiotic exposure is the single strongest risk factor for C. difficile infection, with one-third of colonized patients developing symptomatic infection within 2 weeks of antibiotic therapy, according to the Journal of the American Geriatrics Society 2, 3
Healthcare-associated diarrhea places patients in a high-risk category where testing is specifically recommended by the Infectious Diseases Society of America 4
The diagnosis should be strongly considered if the patient has received antibiotics or chemotherapy in the previous 4-6 weeks, as stated by the Journal of the American Geriatrics Society 2, 6

Antiperistaltic agents like loperamide are absolutely contraindicated in C. difficile infection, as they worsen disease severity, mask symptoms, and precipitate toxic megacolon, according to the American College of Gastroenterology 1
The mechanism of slowing intestinal transit traps C. difficile toxins against the colonic wall, allowing deeper tissue damage while hiding clinical warning signs of deterioration 1

The recommended testing algorithm is a two-step approach: GDH screening followed by toxin testing, or NAAT followed by toxin confirmation, which balances sensitivity and specificity while avoiding false positives from colonization, as recommended by the Infectious Diseases Society of America 5, 7
Single toxin EIA alone is not recommended due to insufficient sensitivity, according to the Infectious Diseases Society of America 7

If testing confirms C. difficile infection, appropriate management includes discontinuing the causative antibiotic if clinically feasible, as continued antibiotic use significantly increases recurrence risk, according to the World Journal of Emergency Surgery 8
Oral vancomycin 125 mg four times daily for 10 days is first-line therapy for initial episodes, with a clinical success rate of approximately 81%, as recommended by the Infectious Diseases Society of America 8, 7

If symptomatic management is needed while awaiting results or if C. difficile is confirmed, opioids and octreotide can be used as alternatives to traditional antimotility agents, which avoid catastrophic complications, according to the American College of Gastroenterology 1

Handwashing with soap and water is mandatory, as alcohol-based sanitizers do not inactivate C. difficile spores, according to the Centers for Disease Control and Prevention 2, 3, 6
Mechanical removal of spores through friction and running water is the only effective hand hygiene method, as stated by the World Health Organization 3, 6